Literature DB >> 15965425

Childhood dermatofibrosarcoma protuberans: role of preoperative imaging.

Sharon Longshore Thornton1, Janet Reid, Francis A Papay, Allison T Vidimos.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is especially challenging to recognize and diagnose in children. Prompt and definitive treatment is essential based on the tumor's high rate of recurrence. Our purpose is to increase physician awareness and recognition of DFSP in the pediatric population with the largest case series of childhood DFSP to our knowledge thus reported in the literature. We also propose that magnetic resonance imaging (MRI) may be useful in the preoperative assessment. The records of 10 patients with primary DFSP between the ages of 8 months and 16 years were reviewed. Only 1 of 10 patients was given the correct diagnosis at the initial medical evaluation. Of the 10 cases, 5 were congenital. The average delay in diagnosis was 5 years. Of the patients, 5 had preoperative MRI to delineate the size and extent of the tumor. In the two cases with the largest tumors preoperative MRI significantly altered surgical planning and execution. Thus, preoperative MRI may be helpful in planning for successful surgical clearance of large tumors and preventing local recurrence. All 10 cases were treated with Mohs micrographic surgery and no recurrences were noted with a follow-up range of 6 weeks to 17 years.

Entities:  

Mesh:

Year:  2005        PMID: 15965425     DOI: 10.1016/j.jaad.2004.11.071

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  Dermatofibrosarcoma protuberans-a rare neoplasm.

Authors:  Awaji Qasim Al-Naami; Liaqat Ali Khan; Khadija Amin; Abdu-Rahman Mohammad Al-Naami; Zhonghua Sun
Journal:  Quant Imaging Med Surg       Date:  2016-04

Review 2.  Dermatofibrosarcoma protuberans with fibrosarcomatous transformation of the head and neck.

Authors:  Nikolaos Angouridakis; Panagiotis Kafas; Waseem Jerjes; Stefanos Triaridis; Tahwinder Upile; Georgios Karkavelas; Angelos Nikolaou
Journal:  Head Neck Oncol       Date:  2011-02-04

3.  Status report on the management of dermatofibrosarcoma protuberans: is there a viable role for the use of imatinib mesylate? In which cases may it be therapeutically helpful and in which cases not?

Authors:  Grace K Kim
Journal:  J Clin Aesthet Dermatol       Date:  2011-03

Review 4.  Dermatofibrosarcoma Protuberans in Children.

Authors:  Aseel Sleiwah; Thomas C Wright; Thomas Chapman; Adam Dangoor; Francesca Maggiani; Rachel Clancy
Journal:  Curr Treat Options Oncol       Date:  2022-04-08

Review 5.  Current treatment options in dermatofibrosarcoma protuberans.

Authors:  Doreen Lemm; L-O Mügge; T Mentzel; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-10       Impact factor: 4.553

6.  Dermatofibrosarcoma Protuberans: Computed Tomography and Magnetic Resonance Imaging Findings.

Authors:  Liang Zhang; Qing-Yu Liu; Yun Cao; Jin-Shuang Zhong; Wei-Dong Zhang
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.